Page images
PDF
EPUB

- 2

Attachment 6

The Price Schedule: Category "B", which applied only to Gammacorten, no longer appears.

Prices are decreased on: Carme those Liquid, 1 gal-
lon; Coramine Ampuls 1.5 ml., 100; Coramine Ampuls
5 ml., 100; Regitine Ampuls 1 ml., 6. These particu-
lar packages are used primarily in hospitals and there-
fore are not normally in stock except in hospital phar-
macies. However, if you happen to have any full pack-
ages and notify us, we shall be happy to make adjust-
ments on your shelf stocks.

There are basic price increases on Ritalin, Ritonic,
Ismelin, and a number of other changes.

Regitine Tablets 100, formerly in the line, are again
listed.

Entero-Vioform Tablets 20's are no longer available.

Orders invoiced by CIBA in April are not subject to
this new schedule. May 1, 1963, is the date it is
effective.

Finally, in an effort to improve the functional qualities of our packages, we have redesigned the labels. Your CIBA products are beginning to appear in this new dress, which is designed to increase readability. We hope you like it.

CIBA PHARMACEUTICAL COMPANY

CUTTER LABORATORIES

FOURTH & PARKER STREETS
BERKELEY 10, CALIFORNIA

October 25, 1965

Mr. Merritt L. Skinner, R. Ph.

Skinner's Pharmacy

222 North Michigan Plymouth, Indiana

Dear Mr. Skinner:

Thank you for your letter of October 6 and your questionnaire regarding our minimum purchase requirements and quantity discounts used in our distribution of pharmaceutical products.

Statement

The difficulty we encountered when attempting to answer your Summary Pricing Structure was that our discounts and minimum purchase requirements are of such diverse nature that we found it impossible to apply them to your individual questions and still assure that you would obtain an understandable picture of our marketing structure. The complexity of our quantity discounts and minimum purchase requirements would almost dictate an extended personal face to face discussion for purposes of explaining all exceptions and qualifications in detail. We do appreciate, however, that you have included us in your survey of pharmaceutical manufacturers and hope that we can be of more help on

some future occasion.

Sincerely yours,

Peter 1. Wittkules

Peter J. Wittkuhns
Pricing Supervisor

PJW:jd

[blocks in formation]

1.

[ocr errors]
[ocr errors]
[ocr errors]

no

[ocr errors]

Do you have a minimum shipment limit (yes chas
order (yes, no_
no _), minimum dollar
) or minimum dollar purchase per year (yes
Please explain and state pertinent amounts:

[ocr errors]

2.

3.

What discounts from your catalogue prices do you allow for minimum purchases by each of the following? What additional discounts are given for quantity purchases?

a) Individually owned community pharmacies (discounts):

(additional discounts/quantity):

b) Chain drug

[ocr errors]

stores who maintain warehouse facilities (discount):

(additional discounts/quantity):

L

c) Conventional drug wholesalers (discount):

(additional discounts/quantity):_

d) Physicians in individual private practice (discount): 1/4

(additional discounts/quantity):

[ocr errors]

e) Privately owned medical clinics or proprietary hospitals (discount):

(additional discounts/quantity):

f) Tax supported institutions, such as community, state or federal hospitals

[merged small][ocr errors][merged small][merged small]

Does your company respond to bid offers from federal or state governments, hospitals or other large community purchasers? (yes, no

Please explain:

[blocks in formation]

Thank you very much for your recent letter concerning the distribution practices employed by pharmaceutical manufacturers. Also, please excuse our delay in replying. I just returned from an extended business

trip.

Rather than follow point by point the outline in your questionnaire, I would prefer to summarize our policy briefly since we do not find the questionnaire particularly applicable in our case.

Geigy pharmaceuticals are distributed to retail pharmacies and hospitals through selected wholesale druggist distributors, thus we do not sell community pharmacies, chain drug stores or chain drug store warehouses on a direct basis.

We bill our wholesalers at 20% from our "Wholesale Druggist Distributors' Schedule Suggested Prices to Pharmacists."

We do not sell physicians in private practice on a direct basis.

We do not sell medical clinics on a direct basis.

For competitive reasons, we will sell tax supported institutions and hospitals on a direct basis, with over two-thirds of our hospital sales volume concentrated in federal and state government hospitals as well as other tax supported institutions.

We hope that you find this information useful. can help in any other way.

Please contact us if we

Yours very truly,

TEK: B

GEIGY PHARMACEUTICALS

Division of Geigy Chemical Corporation

sumidy

Thomas E. Kennedy

Manager, Trade Relations

[blocks in formation]
« PreviousContinue »